Assays for the detection of anti-TNF drugs and autoantibodies
US10386366B2 · kind B2 · utility
2Cited by
25References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2016 |
| Grant date | Aug 20, 2019 |
| Priority date | — |
| Expiry date | Dec 14, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides assays for detecting and measuring the presence or level of anti-TNFα drug therapeutics and autoantibodies in a sample. The present invention is useful for optimizing therapy and monitoring patients receiving anti-TNFα drug therapeutics to detect the presence or level of autoantibodies (e.g., HACA and/or HAHA) against the drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.